Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

NCT00837434 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

63

Enrollment

NIH

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Etanercept
DRUG: Adalimumab

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]